Stay informed on coronavirus (COVID-19).    Read More

Header Image

YUTIQ® Now available through MinibarRx®

Phone: (800) 843-7477 x2317   |   Email: SDRNon-AcuteTeam@fffenterprises.com

FFF Enterprises, Inc. is excited to offer retina specialist offices the opportunity to purchase YUTIQ® (fluocinolone acetonide intravitreal implant) 0.18 mg ophthalmic intravitreal injection, through MinibarRx®

— a SMART system designed specifically for handling inventory management through our Forward-Deployed Inventory (FDI) consignment program.

Program Benefits:

  • Our FDI consignment program provides on-site, on-demand access to YUTIQ®
  • Reduce inventory carrying costs by only paying for pharmaceutical products when they are dispensed from the MinibarRx cabinet
  • FFF Enterprises, the nation's most trusted specialty distributor since 1988, serves as the exclusive distribution partner providing your MinibarRx system with the on-demand pharmaceuticals, including ophthalmology products, that meet your patients' needs.

Indications and Usage

YUTIQ, manufactured by EyePoint Pharmaceuticals, contains a corticosteroid and is indicated for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye.


YUTIQ is a non-bioerodible intravitreal implant in a drug delivery system containing 0.18 mg fluocinolone acetonide, designed to release fluocinolone acetonide at an initial rate of 0.25 mcg/day, and lasting 36 months.


YUTIQ (fluocinolone acetonide intravitreal implant) 0.18 mg ophthalmic intravitreal injection is supplied in a sterile single-dose preloaded applicator with a 25-gauge needle, packaged in a sealed sterile foil pouch inside a sealed Tyvek pouch inside a carton box.


NDC: 71879-136-01

Storage: Store at 15° C to 30° C (59° F to 86° F).


To learn more about YUTIQ, please read the full Prescribing Information.


Contact Information
Organization
©2021 MinibarRx®, a subsidiary of FFF Enterprises, Inc. All rights reserved.